Instant Access to a Merck representative at
your convenience
Merck OnCall works as an adjunct to field-based representatives to provide health care professionals with services and resources, such as:
- Product information updates
- Complimentary samples
- Patient education materials
- Assistance and updates on Merck Web sites
- Access to a medical services pharmacist
| Hours of Operation We are available to help you: |
|
|---|---|
| Monday | 8 AM – Midnight ET |
| Tuesday | 8 AM – Midnight ET |
| Wednesday | 8 AM – Midnight ET |
| Thursday | 8 AM – Midnight ET |
| Friday | 8 AM – 6 PM ET |
| Saturday | 8 AM – 3 PM ET |
Merck OnCall: Reaching Goals at Merck
Merck OnCall is ready to help you better understand and utilize the many products and services available at Merck.
Our customer support services are designed to accommodate your busy schedule and provide information about Merck products in a timely, accurate fashion. You can contact Merck OnCall at your convenience and be confident you'll receive the same high caliber of service you'd expect from your local Merck representative.
Within minutes, arrange a
Merck OnCall Web conference with
a live Merck representative.
Get products and services
information from the source:
800-235-1432.
Watch a video tour of Merck OnCall.
Frequently asked questions about Merck OnCall.
SINGULAIR is indicated for prophylaxis and chronic treatment of asthma in patients aged 12 months and older and for prevention of exercise-induced bronchoconstriction (EIB) in patients aged 15 years and older.
For prevention of EIB, a single dose of SINGULAIR should be taken at least 2 hours before exercise. An additional dose of SINGULAIR should not be taken within 24 hours of a previous dose.
Patients already taking 1 tablet daily for another indication should not take an additional dose to prevent EIB.
SELECTED SAFETY INFORMATION
- SINGULAIR should not be used as rescue medication to treat acute asthma episodes. Patients should be advised to have appropriate rescue medication available.
- Neuropsychiatric events have been reported in patients taking SINGULAIR. These events included agitation, aggressive behavior or hostility, anxiousness, depression, dream abnormalities, hallucinations, insomnia, irritability, restlessness, somnambulism, suicidal thinking and behavior (including suicide), and tremor. The clinical details of some postmarketing reports appear consistent with a drug-induced effect. Patients should be advised to report any neuropsychiatric events.
- Use of SINGULAIR may not eliminate the need for inhaled or systemic corticosteroids. Patients should not decrease the dose or stop taking any other antiasthma medications unless instructed by a physician.
- Safety and effectiveness of SINGULAIR in patients younger than 12 months with asthma have not been established.
Before prescribing SINGULAIR, please read the Prescribing Information.